ARYx Therapeutics, Inc. — Form D
ARYx Therapeutics, Inc. of FREMONT, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-13. The offering totals $35.4M, of which $357K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-11-13
- Form: D
- Accession: 0001288649-09-000004
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $35.4M
- Amount sold: $357K
- Remaining: $35.0M
- Investors: 1
- Date of first sale: 2009-10-06
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-124990
Issuer
- Name: ARYx Therapeutics, Inc.
- CIK: 0001410064
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 6300 DUMBARTON CIRCLE, FREMONT, CA, 94555
- Phone: (510) 585-2200
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| David G Beier | Director | Fremont, CA |
| Lars G Ekman | Director | Palo Alto, CA |
| Keith G Leonard | Director | Fremont, CA |
| Peter G Milner | Director | Ft. Thomas, KY |
| Herm G Rosenman | Director | Fremont, CA |
| Paul G Sekhri | Director | Boston, MA |
| Nick G Simon | Director | Fremont, CA |
| Daniel G Canafax | Executive Officer | Fremont, CA |
| Pascal G Druzgala | Executive Officer | Fremont, CA |
| Peter G Milner | Executive Officer | Ft. Thomas, KY |
| David G Nagler | Executive Officer | Fremont, CA |
| John G Varian | Executive Officer | Fremont, CA |
| Paul Sekhri | Director | New York, NY |
| Lars Ekman | Director | San Diego, CA |
| Pascal Druzgala | Executive Officer | Menlo Park, CA |
| Paul Goddard | Director | San Francisco, CA |
| Paul Goddard | Executive Officer | San Francisco, CA |
| Nick Simon | Director | South San Francisco, CA |
| Keith Leonard | Director | Calabasas, CA |
| David Beier | Director | Fremont, CA |
| John Varian | Executive Officer | Fremont, CA |
| David Nagler | Executive Officer | Fremont, CA |
| Hermn Rosenman | Director | Fremont, CA |
Other filings by this issuer (1)
More